The Role of Surgical Intervention in Laryngopharyngeal Reflux Disease
Otolaryngologic Clinics of North America · 2025-06 · 58 (3) · 529-536
DOI: 10.1016/j.otc.2025.01.008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Otolaryngologic Clinics of North America, 2025-06. Verfasst von Vivian Hsiao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Washington, 1949 NE Pacific Street, Box 356410, Seattle, WA 98195, USA. Hauptthemen laut MEDLINE: Laryngopharyngeal Reflux, Fundoplication, Esophageal Sphincter, Upper. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
This article covers surgical interventions for laryngopharyngeal reflux disease (LPRD), focusing on upper esophageal sphincter augmentation, fundoplication, and magnetic sphincter augmentation. It discusses indications, procedural details, and an overview of current evidence for surgical management of refractory LPRD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University of Washington, 1949 NE Pacific Street, Box 356410, Seattle, WA 98195, USA.
- Department of Surgery, University of Washington, 1949 NE Pacific Street, Box 356410, Seattle, WA 98195, USA. Electronic address: edfigue@uw.edu.
Zitieren
APA
Hsiao, V., & Figueredo, E. J. (2025). The Role of Surgical Intervention in Laryngopharyngeal Reflux Disease. Otolaryngologic Clinics of North America, 58(3), 529-536. https://doi.org/10.1016/j.otc.2025.01.008
Vancouver
Hsiao V, Figueredo EJ. The Role of Surgical Intervention in Laryngopharyngeal Reflux Disease. Otolaryngologic Clinics of North America. 2025;58(3):529-536. doi:10.1016/j.otc.2025.01.008
BibTeX
@article{Hsiao2025,
author = {Hsiao, Vivian and Figueredo, Edgar J},
title = {The Role of Surgical Intervention in Laryngopharyngeal Reflux Disease},
journal = {Otolaryngologic Clinics of North America},
year = {2025},
volume = {58},
number = {3},
pages = {529--536},
doi = {10.1016/j.otc.2025.01.008}
}
EUVIMED